Mikhail Blagosklonny Develops TOR for Cancer Treatment and Aging Introduction

Cancer is one of the leading causes of death globally. Tackling it requires concerted efforts from individuals and organizations. Research-based solutions offer great promise of addressing this global scourge. One of such people who has endeavored towards finding research-based cancer treatments and therapies is Mikhail Blagosklonny, a scientist who has invested millions of dollars to fund cancer research. Blagosklonny has vastly contributed to the fight against cancer by revolutionizing modern cancer treatment. Visit ResearchGate to keep up to date with Mikhail’s latest work.

Contributions

Mikhail Blagosklonny is a famous oncology research scientist having authored more than 180 articles on cancer and advanced treatment. Additionally, Mikhail has co-authored books on research reviews based on cellular biology surrounding cancer linked to their cycle. His research capitalizes on aging and molecular theory. On aging, Mikhail proposed the TOR signaling hypothesis. TOR plays a significant role in the human body cell by prolonging life. It inhibits apoptosis, hence delaying autophagy. The result is promoted protein synthesis. The processes delay aging of the body cells hence prolonged lives. It also delays the onset of old age diseases. According to Blagosklonny, over production of TOR signaling resulted in autophagy hence cancerous tumors. A clear understanding of these processes is essential in the generation of valuable anti-cancer drugs.

Education and Career

Apart from being a research scientist, Mikhail is a scholar. He is a professor at Roswell Park Institute of Cancer Research. Prior to his appointment at the Roswell Research Centre, Mikhail worked as a research scientist at the research institute of Ordway. With a background and academic credentials in research, he was appointed an associate professor at the New York Medical College. Mikhail attended the First Pavlov State Medical. He has degrees in Philosophy and Medicine. He also went to St. Petersburg University for further studies. He serves as the lead editor for Oncotarget, a journal with educative articles on cancer and its treatment.

About Mikhail Blagosklonny

Mikhail is the lead scientist at Roswell Research Institute for Cancer. Under his leadership, the institute has continued to be identified as a major research center for fighting cancer. His prominence roots from his ability to develop groundbreaking research on cancer and its treatment. Follow Mikhail on Google Scholar